To correlate the data obtained by Electrical impedance tomography (EIT) during the spontaneous breathing trials (SBT) on a T-piece, in children, with failure in the trial and Extubation failure.
Observe if the EIT monitoring will be able to detect the children that will fail earlier than the SBT performed alone.
Method: A cross-sectional, prospective study to explore the potential benefits of monitoring with EIT during weaning.
Condition or disease | Intervention/treatment |
---|---|
Ventilator Weaning Child Spontaneous Breathing Trial Electrical Impedance Tomography | Device: Electrical Impedance tomography |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 134 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 2 Years |
Official Title: | The Role of Chest Electrical Impedance Tomography in the Pediatric Ventilator Weaning |
Estimated Study Start Date : | September 24, 2019 |
Estimated Primary Completion Date : | September 4, 2020 |
Estimated Study Completion Date : | September 4, 2021 |
Evaluate Electrical impedance tomography Security (skin lesion or pain)
Neonatal Skin Condition Score
Dryness
Erythema
Breakdown
Note:
Perfect score = 3 Worst score = 9
Tracking Information | |||||||||
---|---|---|---|---|---|---|---|---|---|
First Submitted Date | July 3, 2019 | ||||||||
First Posted Date | July 9, 2019 | ||||||||
Last Update Posted Date | September 26, 2019 | ||||||||
Estimated Study Start Date | September 24, 2019 | ||||||||
Estimated Primary Completion Date | September 4, 2020 (Final data collection date for primary outcome measure) | ||||||||
Current Primary Outcome Measures |
|
||||||||
Original Primary Outcome Measures | Same as current | ||||||||
Change History | |||||||||
Current Secondary Outcome Measures |
|
||||||||
Original Secondary Outcome Measures |
|
||||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||||
Descriptive Information | |||||||||
Brief Title | The Role of Chest Electrical Impedance Tomography in the Pediatric Ventilator Weaning | ||||||||
Official Title | The Role of Chest Electrical Impedance Tomography in the Pediatric Ventilator Weaning | ||||||||
Brief Summary |
To correlate the data obtained by Electrical impedance tomography (EIT) during the spontaneous breathing trials (SBT) on a T-piece, in children, with failure in the trial and Extubation failure. Observe if the EIT monitoring will be able to detect the children that will fail earlier than the SBT performed alone. Method: A cross-sectional, prospective study to explore the potential benefits of monitoring with EIT during weaning. |
||||||||
Detailed Description | Early and successful Extubation is sometimes a difficult combination in children, since the criteria for suggesting it are often subjective and poorly defined. Electrical impedance tomography (EIT) has been developed and used clinically for more than 30 years. Interest in this technology arose from the need to monitor ventilation and pulmonary perfusion at the bedside. Because it is a non-invasive and non-radiation technology, EIT is very promising in the pediatric population. Objectives: To correlate the data obtained by the EIT during the spontaneous breathing trials (SBT) on a T-piece with failure in the trial and Extubation failure and to observe if the EIT is able to detect the children that will fail earlier than the SBT performed alone. Method: A cross-sectional, prospective study to explore the potential benefits of monitoring with EIT during weaning. Qualitative characteristics will be described using absolute and relative frequencies and the quantitative characteristics will be described using summary measures (mean, standard deviation, median, minimum and maximum). Bivariate and later multiple logistic regression analyzes will be performed to evaluate the influence of characteristics assessed on weaning failure, mainly the reduction in functional residual capacity during and after the weaning trial. For the analysis will be used the software IBM-SPSS for Windows version 20.0 and tabulation of the data will be used Microsoft Excel 2010 software. The tests will be performed with significance level of 5%. | ||||||||
Study Type | Observational [Patient Registry] | ||||||||
Study Design | Observational Model: Cohort Time Perspective: Prospective |
||||||||
Target Follow-Up Duration | 2 Years | ||||||||
Biospecimen | Not Provided | ||||||||
Sampling Method | Non-Probability Sample | ||||||||
Study Population | Children who are on mechanical ventilation for a period of more than 24 hours, between 28 days of age and 15 years, who are admitted to the pediatric intensive care unit (ICU) of the Children's Institute in Brazil and are ready for a weaning trial. | ||||||||
Condition |
|
||||||||
Intervention | Device: Electrical Impedance tomography
Monitoring with Electrical impedance tomography during spontaneous breathing trials on T-piece in children
|
||||||||
Study Groups/Cohorts | Not Provided | ||||||||
Publications * | Not Provided | ||||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
Recruitment Information | |||||||||
Recruitment Status | Recruiting | ||||||||
Estimated Enrollment |
134 | ||||||||
Original Estimated Enrollment | Same as current | ||||||||
Estimated Study Completion Date | September 4, 2021 | ||||||||
Estimated Primary Completion Date | September 4, 2020 (Final data collection date for primary outcome measure) | ||||||||
Eligibility Criteria |
Inclusion Criteria: Children who are on mechanical ventilation for a period of more than 24 hours, between 28 days of age and 15 years, who are admitted to the pediatric intensive care unit (ICU) of the Children's Institute in Brazil Exclusion Criteria:
|
||||||||
Sex/Gender |
|
||||||||
Ages | up to 15 Years (Child) | ||||||||
Accepts Healthy Volunteers | No | ||||||||
Contacts |
|
||||||||
Listed Location Countries | Brazil | ||||||||
Removed Location Countries | |||||||||
Administrative Information | |||||||||
NCT Number | NCT04011852 | ||||||||
Other Study ID Numbers | 10055719.0.0000.0068 | ||||||||
Has Data Monitoring Committee | No | ||||||||
U.S. FDA-regulated Product |
|
||||||||
IPD Sharing Statement |
|
||||||||
Responsible Party | University of Sao Paulo General Hospital | ||||||||
Study Sponsor | University of Sao Paulo General Hospital | ||||||||
Collaborators | Not Provided | ||||||||
Investigators |
|
||||||||
PRS Account | University of Sao Paulo General Hospital | ||||||||
Verification Date | July 2019 |